Pricing Log in Create free account

Jupiter Neurosciences, Inc. (JUNS) vs KALA BIO, Inc. (KALA)

Jupiter Neurosciences, Inc. and KALA BIO, Inc. are both Biotechnology companies. Jupiter Neurosciences, Inc. and KALA BIO, Inc. are of similar size ($3.0M and $2.8M). Across the 8 metrics below, KALA BIO, Inc. leads on 5 and Jupiter Neurosciences, Inc. on 3.

Valuation

Metric JUNS KALA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.52 9.40
P/B n/m 0.33 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.01 n/m 0.66
EV/Sales n/m 8.04 9.02
Earnings yield (842.19%) (31,890.31%) (32.88%)
Free cash flow yield (572.73%) (667.16%) (23.13%)

Profitability

Metric JUNS KALA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,888.80%) (345.32%) (51.96%)
Return on assets (239.36%) (43.23%) (46.06%)
Return on invested capital 0.00% (722.69%) 0.00%

Growth

Metric JUNS KALA Biotechnology median
Revenue growth (TTM) — (50.54%) 6.76%
EPS growth (last fiscal year) (212.50%) 67.39% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric JUNS KALA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.66 6.88 4.97
Net debt to EBITDA 0.43 0.19 1.01

Dividend

Metric JUNS KALA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JUNS KALA Biotechnology median
Market cap 2.81m 2.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack